T. Rowe Price Associates’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-81,560
| Closed | -$334K | – | 3028 |
|
|
2022
Q1 | $334K | Buy |
81,560
+36,303
| +80% | +$149K | ﹤0.01% | 2504 |
|
|
2021
Q4 | $162K | Sell |
45,257
-3,200
| -7% | -$11.5K | ﹤0.01% | 2801 |
|
|
2021
Q3 | $176K | Buy |
48,457
+815
| +2% | +$2.96K | ﹤0.01% | 2747 |
|
|
2021
Q2 | $208K | Buy |
47,642
+20,094
| +73% | +$87.7K | ﹤0.01% | 2710 |
|
|
2021
Q1 | $113K | Buy |
27,548
+16,312
| +145% | +$66.9K | ﹤0.01% | 2767 |
|
|
2020
Q4 | $45K | Sell |
11,236
-600
| -5% | -$2.4K | ﹤0.01% | 2650 |
|
|
2020
Q3 | $32K | Hold |
11,836
| – | – | ﹤0.01% | 2558 |
|
|
2020
Q2 | $33K | Buy |
11,836
+608
| +5% | +$1.7K | ﹤0.01% | 2474 |
|
|
2020
Q1 | $26K | Buy |
11,228
+1,038
| +10% | +$2.4K | ﹤0.01% | 2479 |
|
|
2019
Q4 | $48K | Buy |
+10,190
| New | +$48K | ﹤0.01% | 2488 |
|